Bridgewater Associates’s Burning Rock Biotech BNR Stock Holding History

Bridgewater Associates’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,675	Closed	-$36.5K	–	749
2023 Q2	$36.5K	Sell	1,675 -4,807	-74%	-$128K	﹤0.01%	696
2023 Q1	$182K	Sell	6,482 -2,047	-24%	-$61.3K	﹤0.01%	703
2022 Q4	$192K	Sell	8,529 -143	-2%	-$3.26K	﹤0.01%	808
2022 Q3	$207K	Sell	8,672 -297	-3%	-$9.59K	﹤0.01%	853
2022 Q2	$261K	Sell	8,969 -6,872	-43%	-$307K	﹤0.01%	956
2022 Q1	$1.47M	Sell	15,841 -3,519	-18%	-$306K	0.01%	743
2021 Q4	$1.84M	Buy	19,360 +3,540	+22%	+$485K	0.01%	474
2021 Q3	$2.83M	Buy	15,820 +12,424	+366%	+$2.76M	0.02%	379
2021 Q2	$1M	Buy	+3,396	New	+$1M	0.01%	586

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bridgewater Associates's BNR Position: Q3 2023 in Review

Bridgewater Associates sold out of Burning Rock Biotech (BNR) in Q3 2023, closing a stake of 1,675 shares — an estimated $36.5K sold.

Bridgewater Associates first reported a position in BNR in Q2 2021 and held it in 9 quarters. The position peaked at $2.83M in Q3 2021. 28 funds tracked by Wall St. Rank hold BNR as of Q3 2023.

Bridgewater Associates reported no remaining Burning Rock Biotech position as of Q3 2023 after selling out during the quarter.
Bridgewater Associates sold 1,675 Burning Rock Biotech shares in Q3 2023, an estimated $36.5K.
Bridgewater Associates first reported a position in Burning Rock Biotech in Q2 2021 and held it in 9 quarters.
Bridgewater Associates's Burning Rock Biotech position peaked at $2.83M in Q3 2021.
28 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.